SOLACI Symposium at the EuroPCR 2025 Congress

The Latin American Society of Interventional Cardiology (SOLACI) makes a strong appearance once again at one of the most important congresses in the field worldwide. In this regard, the Society will participate in the EuroPCR 2025 Congress (to be held in Paris, France, from May 20 to 23) with a joint session on “Clinical and technical factors for decision-making in the treatment of left main coronary artery disease.”

The symposium will feature experts from both Latin America and Europe, and its main highlight will be the presentation of the “SOLACI / SIAC Guidelines for Left Main Coronary Artery Revascularization”, the result of extensive work carried out between both scientific societies. The SOLACI / SIAC Guidelines will be simultaneously published in a prestigious international PubMed-indexed journal at the time of the session.

May 22, 2025 | 09:45 am to 10:45 am (UTC +2) | Room 252B

Below are the session details. We look forward to seeing you all in Paris!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Data Update Campaign for SOLACI Members. Let’s Stay Connected

Data Update for SOLACI Members. We aim to keep our members informed about all developments and matters related to the association. In this regard, we...

Highlights of the SOLACI@EuroPCR 2025 Session

Relive the best moments of the joint session organized by SOLACI during the EuroPCR 2025 Congress on “Clinical and technical factors for decision-making in...

See the best images from the Uruguay 2025 Sessions

Enjoy the best moments of the Uruguay 2025 Conference, held at the Radisson Hotel in Montevideo (Uruguay) on May 7, 8, and 9, 2025. <!--...

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

In a constant strive to achieve life time management, interventional cardiologists focus on optimizing coronary scaffolds, which calls for the development of devices with...

Three-Year Outcomes of Mitral Valve-in-Valve Therapy with Balloon-Expandable Valves in the United States

Gentileza del Dr. Juan Manuel Pérez. Mitral Valve-in-Valve (MViV) implantation with balloon-expandable valves has become a solid alternative for patients with degenerated mitral bioprostheses. However,...

Edge-to-Edge Treatment in Cardiogenic Shock

Cardiogenic shock (CS) is characterized by severe ventricular dysfunction, most often of ischemic origin. It is frequently associated with severe mitral regurgitation (MR), either...